Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors

NCT02038218 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Brain Tumors
Metastatic Malignant Neoplasm to Brain

Interventions

DRUG: 4-Demethyl-4-cholestryloxycarbonylpenclomedine

Sponsor

DEKK-TEC, Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]